Testing For the HIV and AIDS Virus
The Centers for Disease Control recommends HIV testing as part of routine medical care for everyone between the ages of 13 to 64. This may seem like a drastic step but they recommended this step in September 2006. That should tell you how serious they consider the disease of AIDS. The CDC suggests
that everyone have at least one test in his or her lifetime but yearly tests should be conducted for those people at high risk.
The sad fact about HIV testing is that it is not accurate immediately after a person has been infected. It takes about twelve weeks for HIV antibodies to develop. In some rare cases it may take six to twelve months for the body to show these antibodies. If you don’t realize you may be at risk, signs and symptoms of HIV and AIDS will not show up for up to ten years. This is a scary thought because even though the signs and symptoms are not visible, they can still infect other people with the virus.
For many years the only test for the HIV virus was the ELISA test that looks for the antibodies in a sample of blood. The emotional toll can be terrible because with the early tests it would take up to two weeks to receive the results. If the first results are possible, then a second test is performed to confirm the first test. The second test is called the Western Blot test. Combining the results of the two tests will tell you if you have HIV. The first test could give you a false positive that is why it is so important to follow through with the another testing.
Today there are newer and more effective tests that also will give the results quicker. Some tests will show results in as little as twenty minutes. These tests will use a sample of your blood or from material collected from your upper and lower gums. This test is just as effective as the blood test and eliminates drawing blood and the risk of an accidental needle prick to the health giver. If the test shows positive, a second blood test will be required with drawn blood. The tests are new and certified to be used in laboratories only, so they may not be available to all areas of the country.
Anyone who can surf the Internet can find many home HIV tests. This gives you the opportunity to have the test in the privacy of your home without going to a doctor or a clinic. These tests cannot be legally marketed in the United States. The Food and Drug Administration has approved one HIV test for home use. Home Access Health makes it and if the test is positive, the test results are retested. It isn’t like a home pregnancy test. You are asked to send in a drop of your blood then call in to a toll-free number to receive the results of the test. You are guaranteed privacy and anonymity because you are identified only with a code number that is in your testing kit.
Important Information in AIDS and HIV Issues
Warning: curl_setopt() [function.curl-setopt]: CURLOPT_FOLLOWLOCATION cannot be activated when in safe_mode or an open_basedir is set in /home/freenow1/public_html/THE-HEALTH-AND-WELLNESS-CENTER.COM/aids/aids-rss2html.php on line 149
09/07/2010
HIV/AIDS awareness inspires alumnus’ trip
University graduate Karl Enchelmayer is hitting the road. He began a 5,000-mile bike ride earlier this month that will take him through redwood forests and across national deserts in hopes of helping people living with HIV/AIDS. The cross-country trip — a nonprofit campaign in partnership with AIDS Athens that will take Enchelmayer from Seattle, Wash., to Miami, [...]
HIV/AIDS awareness inspires alumnus’ trip
09/07/2010
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
NEW YORK, Sept. 7 /PRNewswire-USNewswire/ -- AVAC welcomes the new Global HIV Vaccine Enterprise Scientific Strategic Plan, released today, as a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research. The Plan comes at a crucial time in the field. In the last ...
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
09/07/2010
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
NEW YORK, Sept. 7 /PRNewswire-USNewswire/ -- AVAC welcomes the new Global HIV Vaccine Enterprise Scientific Strategic Plan, released today, as a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research. The Plan comes at a crucial time in the field. In the last ...
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
09/07/2010
Understanding HIV And AIDS
(Ivanhoe Newswire) -- Scientists in Montreal say they've discovered that a specific protein -- called the viral protein R (Vpr) -- may help them better understand HIV and AIDS."We previously identified that HIV, when infecting target cells, blocks cell division and induces cell death," Dr. Eric A. Cohen, was quoted as saying. "We then discovered that the Vpr protein was involved ...
Understanding HIV And AIDS
09/07/2010
HIV project under threat
WESTERN BUREAU:Jamaica's bid to stem HIV/ AIDS, malaria and tuberculosis is poised to hit a snag, as the country's 'upper-middle income' classification renders it ineligible for further financial grants...
HIV project under threat
09/07/2010
Helping immigrants learn to talk openly about AIDS
For African immigrants, who come from countries with high HIV/AIDS rates and where the disease is often considered a death sentence, talking about AIDS in the U.S. is often difficult. That's particularly true for immigrant women, who are often the most difficult to reach with services, say local health providers.
Helping immigrants learn to talk openly about AIDS
09/07/2010
Cheaper HIV Medicine From Boehringer Works Better Than Abbott's in Infants
Boehringer Ingelheim GmbH ’s HIV drug Viramune helped infected infants more than Abbott Laboratories ’ more expensive pill Kaletra in a study, suggesting that the cheaper pill should be used in poorer countries to cut costs.
Cheaper HIV Medicine From Boehringer Works Better Than Abbott's in Infants
|